Manitoba union wants nurse-patient ratios set as soon as possible
Listen to this article Estimated 3 minutes The audio version of this article is generated by AI-based technology.…
Ilant Health Raises $15M to Replace Fragmented Obesity Care With AI-supported, Precision Care
NEW YORK–(BUSINESS WIRE)–Ilant Health, the value-based obesity treatment company working with employers and health plans to deliver clinical…
How Is Pfizer’s Stock Performance Compared to Other Healthcare Stocks?
Pfizer Inc_ logo sign-by JHVEPhoto via iStock With a market cap of $149.2 billion, Pfizer Inc. (PFE) is a…
Elation Health Acquires Aster — Black Women-Founded Health-Tech Startup
Elation Health has announced the acquisition of Aster, a Black-founded EHR focused on women’s health. This acquisition will…
Why Investors Are Suddenly Paying Attention to One of Healthcare’s Most Overlooked Markets
This is sponsored content. Barchart is not endorsing the websites or products set forth below. For decades, women’s…
Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success
The pharmaceutical industry is highly technical and incredibly competitive. That is on clear display right now in the…
HIMS Stock Slides Overnight: CEO Sees Healthcare Potential In Anthropic’s AI Leap As Lilly, WeightWatchers Turn Up The Heat
CEO Andrew Dudum called Anthropic’s latest AI breakthrough “transformative” for population health, saying AI is moving “from super…
Lilly and Novo face off at ADA 2026 as others seek to compete in obesity
This weekend, many of the world’s leading metabolic experts will flock to New Orleans to attend the 2026…
Data raises questions about long-term effects of GLP-1 therapies
Eos SENOLYTIX says new preclinical findings highlight body composition and healthy aging as the next frontier in obesity medicine. A…
WakeMed-Atrium deal could lead to cost hikes for state workers, officials say. WakeMed pushes back :: WRAL.com
State government employees and retirees could see health insurance premiums increase by more than $100 per year if…
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop medicines faster and make smarter decisions throughout…
Jackson memo points to Blue Cross, but records show years of financial trouble
Jackson Hospital’s warning that it could close as early as July is being framed by hospital leaders as…